Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Return on Equity [ROE] (2018 - 2026)

Updated

Moderna (MRNA) reported Return on Equity [ROE] of -44.48% for Q2 2026, down 14.65 percentage points from -29.83% a year earlier and down 4.70 percentage points from the prior quarter.

Analysis

Moderna (MRNA) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Moderna posted Return on Equity [ROE] of -28.87%, down 0.10 percentage points from FY2024.

  • Return on Equity [ROE] has declined for four consecutive years, though with a five-year change of +11.12 percentage points (FY2020 to FY2025).
  • By year, Return on Equity [ROE] came in at -28.77% in FY2024 (-0.18 pp), -28.59% in FY2023 (-78.86 pp), 50.27% in FY2022 (-95.81 pp) and 146.08% in FY2021 (+186.07 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2024.
  • Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of +0.12 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 128.63 percentage points); the low point was Q3 2023 (a drop of 88.20 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -39.78% (Q1 2026), -31.39% (Q4 2025) and -33.27% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 25.32%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 7.21%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 31.52%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 21.39%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -18.38%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 4.97%
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn -44.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.48%
Mar 31, 2026 -39.78%
Dec 31, 2025 -31.39%
Sep 30, 2025 -33.27%
Jun 30, 2025 -29.83%
Mar 31, 2025 -32.02%
Dec 31, 2024 -31.20%
Sep 30, 2024 -18.82%
Jun 30, 2024 -47.84%
Mar 31, 2024 -44.75%
Dec 31, 2023 -34.52%
Sep 30, 2023 -22.80%
Jun 30, 2023 6.74%
Mar 31, 2023 25.19%
Dec 31, 2022 45.06%
Sep 30, 2022 65.40%
Jun 30, 2022 80.18%
Mar 31, 2022 93.77%
Dec 31, 2021 100.56%
Sep 30, 2021 83.92%
API Access

Moderna Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MRNA&period=max&api_key=YOUR_API_KEY